Verrica Pharmaceuticals Inc
NASDAQ:VRCA
Wall Street
Price Targets
VRCA Price Targets Summary
Verrica Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
VRCA
is 13.26 USD
with a low forecast of 8.08 USD and a high forecast of 18.9 USD.
VRCA Last Price Targets
Verrica Pharmaceuticals Inc
The latest public price target was made on Jul 25, 2023 by
Serge Belanger
from
Needham
,
who expects
VRCA
stock to
rise by 28%
over the next 12 months.
You can read more about this price target by viewing
the article on Benzinga.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Serge Belanger
Needham
|
10
USD
Upside 28% |
9 months ago
Jul 25, 2023
|
Verrica's Ycanth Unlikely to Face Near-Term Competition, Analyst Upgrades Stock On FDA Approval
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VRCA's stock price target?
Price Target
13.26
USD
According to Wall Street analysts, the average 1-year price target for
VRCA
is 13.26 USD
with a low forecast of 8.08 USD and a high forecast of 18.9 USD.
What is Verrica Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
193%
The
compound annual growth rate
of Verrica Pharmaceuticals Inc's revenue for the next 3 years is
193%.
You don't have any saved screeners yet
